Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 4Phase NA 3Phase 4 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hemangioma 1Esophageal Stenosis 1Esophageal Neoplasms 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Steroids × Clear all
NCT05768282 2023-03-16

Oral Prednisolone to Prevent Esophageal Stricture After RFA for Long-segment Esophageal Neoplasia

E-DA Hospital

Phase 4 Unknown
50 enrolled
Gastrointestinal

Esophageal Neoplasms, Esophageal Stenosis

NCT01908972 2018-12-19

The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma

Seoul National University Hospital

Phase 4 Completed
34 enrolled 18 charts

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡